What's New in the Law
Highlights of the latest equipment leasing cases from around the country.
Features
Drug & Device News
Analysis of several important happenings.
Features
Third Parties at Court-Ordered Psychological Evaluations
What can litigants, their attorneys, and their medical examiners expect from the courts when conflicts over third-party presence during a court-ordered psychiatric examination arise?
The Role of the Mediator in Med Mal Cases
Tips to make the mediation process smooth and profitable.
Features
A Roadmap to Economic Damages in Med Mal Matters
A good understanding of the basic elements of damages and the issues that might be involved is essential to effective representation. Here is an in-depth review.
Transmission Claims Under the Computer Fraud and Abuse Act
Beyond Computer Fraud and Abuse Act "authorization" claims, parties have also sought to use the CFAA in cases involving unauthorized "transmissions" of information that cause damage.
Features
Real Property Law
In-depth, expert analysis of several key rulings that are important to you and your practice.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- Law Firms and the Rise of HospitalityThe law firm office cannot remain unchanged, as if frozen in time set to some date prior to the onset of pandemic, when the terms and meaning have all changed. In fact, the office must now provide benefits or an experience the lawyers and staff cannot get at home.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Disconnect Between In-House and Outside Counsel'Disconnect Between In-House and Outside Counsel is a continuation of the discussion of client expectations and the disconnect that often occurs. And although the outside attorneys should be pursuing how inside-counsel actually think, inside counsel should make an effort to impart this information without waiting to be asked.Read More ›